1,567
edits
ADRENAL: Difference between revisions
Jump to navigation
Jump to search
m
→Major Points
No edit summary |
m (→Major Points) |
||
| Line 35: | Line 35: | ||
The ADjunctive corticosteroid tREatment iN criticAlly ilL published in 2018 randomized patients with septic shock (ADRENAL) Trial included 3800 patients from 69 international sites, mostly in Australia. Patients were randomized if they were requiring vasopressor support for more than 4 hours and mechanical ventilation. There was no difference at the primary outcome of death from any cause at 90 days, nor were any difference found in any of the six sub-groups. The hydrocortisone group had faster time to reversal of shock, shorter time to discharge from the ICU, time to extubation, and decreased number of blood transfusion. The last of which was hypothesis generating. | The ADjunctive corticosteroid tREatment iN criticAlly ilL published in 2018 randomized patients with septic shock (ADRENAL) Trial included 3800 patients from 69 international sites, mostly in Australia. Patients were randomized if they were requiring vasopressor support for more than 4 hours and mechanical ventilation. There was no difference at the primary outcome of death from any cause at 90 days, nor were any difference found in any of the six sub-groups. The hydrocortisone group had faster time to reversal of shock, shorter time to discharge from the ICU, time to extubation, and decreased number of blood transfusion. The last of which was hypothesis generating. | ||
The 2016 Surviving Sepsis Campaign severe sepsis and septic shock<ref>[http://journals.lww.com/ccmjournal/Abstract/publishahead/Surviving_Sepsis_Campaign___International.96723.aspx Rhodes A, et al. "Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016." ''Critical Care Medicine.'' 2017;45(3)1-67.]</ref> suggests using IV hydrocortisone if hemodynamics cannot be | The 2016 Surviving Sepsis Campaign severe sepsis and septic shock<ref>[http://journals.lww.com/ccmjournal/Abstract/publishahead/Surviving_Sepsis_Campaign___International.96723.aspx Rhodes A, et al. "Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016." ''Critical Care Medicine.'' 2017;45(3)1-67.]</ref> suggests using IV hydrocortisone if hemodynamics cannot be stabilized using fluids and vasopressors. This recommendation was made before the release of the large ADRENAL trial and may lead to re-evaluation of this recommendation. This trial likely puts to rest steroids for all-comers in sepsis but did settle if steroids would be beneficial in patients that are non-responders to initial fluid resuscitation and vasopressor administration. | ||
==Guidelines== | ==Guidelines== | ||